#China #Zibo #Disposable Gloves #INTCO Medical #Production Expansion

Overview of INTCO Medical's Performance

INTCO Medical, a major player in the global disposable glove manufacturing industry, recently reported remarkable financial results for the first half of 2026. The company's revenue skyrocketed by 40.61% year-on-year, reaching approximately 6.91 billion RMB (nearly 1.03 billion USD). This impressive growth also saw the net profit attributable to shareholders increase by 17.86%, totaling about 837.3 million RMB (around 124.6 million USD).

Furthermore, the adjusted net income attributable to shareholders, excluding non-recurring gains and losses, surged by an astounding 165% to reach approximately 1.06 billion RMB (equivalent to 157.7 million USD). These figures illustrate INTCO Medical's robust financial health and strategic market positioning.

Expansion of Production Capacity

As of the end of the reporting period, INTCO Medical's annual production capacity for disposable gloves peaked at 107 billion units, solidifying its status as the world's largest producer in this sector. This output includes 74 billion nitrile gloves and 33 billion vinyl gloves, ensuring a diversified product portfolio for various market demands.

The company’s integrated supply chain covers everything from nitrile latex procurement to research, development, manufacturing, and global marketing. By maintaining a majority or equity stake in nitrile latex manufacturers, INTCO Medical enhances its raw material supply security, successfully mitigating the impacts of international oil price fluctuations on essential raw material costs.

This strategic approach not only improves supply stability but also increases profitability, allowing INTCO Medical to allocate manufacturing resources effectively in response to market demands. Consequently, the company can assure consistent deliveries across global markets, contributing to its operational resilience.

Investment in Research and Development

In the first half of 2026, INTCO Medical's R&D spending jumped by 20.62%, amounting to 245.9 million RMB (roughly 36.6 million USD). The company has continued to innovate, introducing high-performance products such as the Syntex™ synthetic latex gloves, which are free from natural latex proteins and offer superior elasticity and puncture resistance.

Additionally, they launched the Synmax Pro examination gloves, designed for the food service and industrial sectors, along with various safety work gloves and household gloves to meet diverse consumer needs. This commitment to product innovation underscores the company's focus on enhancing the quality and functionality of disposable gloves.

Advancements in Manufacturing Technology

To bolster efficiency and product quality, INTCO Medical has embraced smart manufacturing technologies. The latest nitrile glove production line spans over 1.6 kilometers and features approximately 500 control points. A precision distributed control system automatically manages temperature and fluid levels according to production conditions, reducing labor requirements and energy consumption while ensuring consistent output.

The production yield for gloves has continuously exceeded 99%, demonstrating the effectiveness of these advanced manufacturing processes. INTCO Medical remains dedicated to optimizing its global capabilities and advancing innovative protective products, facilitating its ongoing growth in the competitive disposable glove market.

In conclusion, INTCO Medical's impressive revenue growth, significant production capacity expansion, and commitment to innovation reflect its status as a leading manufacturer in the disposable glove industry. As market demands evolve, INTCO Medical is poised to adapt and excel, ensuring reliable supply and high-quality products for customers worldwide.